Related Experiment Video
Updated: Jun 22, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Connective Tissue Disease Associated Interstitial Lung Disease
Scott M Matson1, M Kristen Demoruelle2
1Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, 3901 Rainbow boulevard, Mailstop 3007, Kansas City, KS 66160, USA.
Connective tissue disease associated interstitial lung disease (CTD-ILD) requires more research. Randomized controlled trials are needed to evaluate immunosuppression and antifibrotic treatments for fibrotic CTD-ILD and subclinical cases.
Area of Science:
- Pulmonology
- Rheumatology
- Immunology
Background:
- Connective tissue disease associated interstitial lung disease (CTD-ILD) presents diverse manifestations.
- Current treatments rely on limited evidence, primarily from scleroderma patients and observational studies in other autoimmune conditions.
Purpose of the Study:
- To highlight the heterogeneity of CTD-ILD.
- To identify critical gaps in evidence for effective treatments.
- To advocate for rigorous clinical trials in specific CTD-ILD populations.
Main Methods:
- Review of existing randomized, placebo-controlled trials (RCTs) in scleroderma-ILD.
- Analysis of observational, retrospective studies in other autoimmune conditions.
- Identification of research needs for fibrotic and subclinical CTD-ILD.
Main Results:
- Limited RCT data exists, primarily for scleroderma.
- Observational data supports immunosuppression in other autoimmune conditions.
- Significant gaps exist in understanding treatment efficacy for fibrotic and subclinical CTD-ILD.
Conclusions:
- There is an urgent need for RCTs evaluating immunosuppression and antifibrotic agents in fibrotic CTD-ILD.
- Further research is required to investigate interventions for patients with subclinical CTD-ILD.
- Addressing these research gaps is crucial for improving patient outcomes in CTD-ILD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Introduction to Connective Tissues
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

